Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
Single-neuron recordings zoom into ‘blurry map’ of human motor cortex
The motor cortex is organized into an "intermixed jumble of tiles" to generate meaningful movement.
Single-neuron recordings zoom into ‘blurry map’ of human motor cortex
The motor cortex is organized into an "intermixed jumble of tiles" to generate meaningful movement.
Exclusive: Neuroscience journal editor resigns over automation concerns
The editor resigned after the publisher’s artificial-intelligence system overrode his selection of referees for a manuscript. His move prompted an internal review of the system.
Exclusive: Neuroscience journal editor resigns over automation concerns
The editor resigned after the publisher’s artificial-intelligence system overrode his selection of referees for a manuscript. His move prompted an internal review of the system.
Are computational complexity principles relevant for explaining brain activity?
Cristopher Moore discusses the nature of computation and whether we should think of neural activity as computing.
Are computational complexity principles relevant for explaining brain activity?
Cristopher Moore discusses the nature of computation and whether we should think of neural activity as computing.